BMS-741672 for Diabetic Neuropathic Pain

Completed · Phase 2 · Has a placebo group

Conditions studied: Neuropathic Pain

In brief

The purpose of the study is to determine whether BMS-741672 improves neuropathic pain in diabetic patients.

Key facts

Study ID

NCT00683423

Run by

Bristol-Myers Squibb

People needed

50

Starts

2008-07-01

Expected to finish

2009-02-01

Last updated by the study team

2015-10-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 1 or 2 diabetics with painful, distal, symmetrical, sensory-motor neuropathy attributed to diabetes, of at least 12 months duration
• Screening HbA1c of ≥ 7% and ≤ 10%
• BMI ≤ 40 kg/m2

You may not qualify if…

• Patients with clinically significant, progressive, or potentially unstable disease of any body system including cardiovascular, gastrointestinal, central nervous system (CNS), psychiatric, endocrine (other than diabetes), tuberculosis or renal
• Women of childbearing potential

Where it is running

• University Clinical Investigators, Inc. — Tustin, California, United States
• Palm Beach Neurological Center — Palm Beach Gardens, Florida, United States
• Comprehensive Neurosciences, Inc. — St. Petersburg, Florida, United States
• The Pain & Rehabilitation Clinic Of Chicago — Chicago, Illinois, United States
• Advanced Biomedical Research Of America — Las Vegas, Nevada, United States
• Physicians East P.A. — Greenville, North Carolina, United States
• Neurology Center Of Ohio — Toledo, Ohio, United States
• Research Institute Of Dallas, P.A. — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.